This interim guidance was initially issued in October 2020, based on advice from the Strategic Advisory Group of Experts (SAGE) on Immunization; it has been updated following the discussions at an extraordinary meeting of SAGE on 29 June 2021. A summary of the major revisions appears in Annex 3 (page 20), including evolving key assumptions and epidemiological considerations.
For further information, see below: